October 6, 2022
Loading...
You are here:  Home  >  Health Care & Life Science  >  Current Article

Amgen partners with Biocartis on diagnostic tests for cancer drug

IN THIS ARTICLE

Biotech giant Amgen signed an agreement with Belgium-based Biocartis Group to assist in the development of companion diagnostic tests for its colorectal cancer drug Vectibix. The Thousand Oaks-based company has partnered with Biocartis to develop its Idylla platform, which uses biomarkers to predict whether a treatment will be effective for a particular patient, since February…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.